Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.06 USD | -0.09% | -0.76% | -10.37% |
02-28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
02-28 | Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M | MT |
Business Summary
Number of employees: 169
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biological Therapeutic Candidates
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -17.88% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -17.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brendan Eckelman
FOU | Founder | 45 | 31/03/10 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 31/03/10 |
Kelly Deck
DFI | Director of Finance/CFO | 44 | 30/09/18 |
Robert Boothroyd
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Vasily Andrianov
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
Ashraf Amanullah
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/07/18 |
Jeffrey Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/19 |
Charbel Helaihel
SAM | Sales & Marketing | - | 31/01/23 |
David Kao
LAW | General Counsel | - | 27/10/21 |
Leah Pollema
LAW | General Counsel | - | 31/12/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Kayyem
BRD | Director/Board Member | 60 | 31/03/18 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 31/03/10 |
Kimberly Manhard
BRD | Director/Board Member | 64 | 31/05/20 |
Doug Forsyth
BRD | Director/Board Member | 55 | 31/03/18 |
Kristiina Vuori
BRD | Director/Board Member | 56 | 27/10/21 |
Brendan Eckelman
FOU | Founder | 45 | 31/03/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,392,447 | 33,862,578 ( 71.45 %) | 0 | 71.45 % |
Company contact information
Inhibrx, Inc.
11025 North Torrey Pines Road Suite 200
92037, La Jolla
+858 795 4220
http://www.inhibrx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.37% | 1.61B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- INBX Stock
- Company Inhibrx, Inc.